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Abstract
Background: Burkholderia cenocepacia is an opportunistic pathogen causing life-threatening infections in patients
with cystic fibrosis. The bacterium survives within macrophages by interfering with endocytic trafficking and
delaying the maturation of the B. cenocepacia-containing phagosome. We hypothesize that B. cenocepacia
undergoes changes in gene expression after internalization by macrophages, inducing genes involved in
intracellular survival and host adaptation.
Results: We examined gene expression by intracellular B. cenocepacia using selective capture of transcribed
sequences (SCOTS) combined with microarray analysis. We identified 767 genes with significantly different levels of
expression by intracellular bacteria, of which 330 showed increased expression and 437 showed decreased
expression. Affected genes represented all aspects of cellular life including information storage and processing,
cellular processes and signaling, and metabolism. In general, intracellular gene expression demonstrated a pattern
of environmental sensing, bacterial response, and metabolic adaptation to the phagosomal environment. Deletion
of various SCOTS-identified genes affected bacterial entry into macrophages and intracellular replication. We also
show that intracellular B. cenocepacia is cytotoxic towards the macrophage host, and capable of spread to
neighboring cells, a role dependent on SCOTS-identified genes. In particular, genes involved in bacterial motility,
cobalamin biosynthesis, the type VI secretion system, and membrane modification contributed greatly to
macrophage entry and subsequent intracellular behavior of B. cenocepacia.
Conclusions: B. cenocepacia enters macrophages, adapts to the phagosomal environment, replicates within a
modified phagosome, and exhibits cytotoxicity towards the host cells. The analysis of the transcriptomic response
of intracellular B. cenocepacia reveals that metabolic adaptation to a new niche plays a major role in the survival of
B. cenocepacia in macrophages. This adaptive response does not require the expression of any specific virulence-
associated factor, which is consistent with the opportunistic nature of this microorganism. Further investigation
into the remaining SCOTS-identified genes will provide a more complete picture of the adaptive response of
B. cenocepacia to the host cell environment.
Background
Burkholderia cenocepacia is a member of the B. cepacia
complex (Bcc), which comprises at least 17 closely related
bacterial species [1,2]. Ubiquitous in nature, Bcc bacteria
thrive in the rhizosphere, fresh and marine water, and in
association with amoebae, fungi, insects, plants and
animals [3,4]. Members of the complex have biopesticidal
and plant growth-promoting properties [5], and due to
their metabolic diversity, also have the ability to degrade
environmental pollutants [6]. The beneficial properties of
Bcc bacteria, however, are offset by their opportunistic
pathogenicity in immunocompromised individuals, espe-
cially in cystic fibrosis (CF) patients [7,8].
Bcc-infected CF patients suffer a rapid decline in lung
function [9], and some develop “cepacia syndrome”, a fatal
condition characterized by rapid lung deterioration, acute,
necrotizing pneumonia, and septicemia [8]. Resistance to
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to-patient transmission further complicate treatment and
prevention [11-13]. Nearly all species of the Bcc have been
identified in the sputum of CF patients, but B. cenocepacia
and B. multivorans are the most prevalent [14,15]. Of
these, B. cenocepacia is associated with epidemic spread
and more severe infection [15,16], and is thus the focus of
this study.
Environmental strains of B. cenocepacia have been iso-
lated from CF patients, indicating a single strain can
occupy multiple niches [12,17]. This suggests an adaptive
capacity of these bacteria to different and potentially
stressful environments, which likely requires gene tran-
scription. B. cenocepacia has a very large genome (~ 8
Mbp) arranged in three chromosomes and one plasmid
[18]. The genome encodes many putative virulence factors,
but none has been shown to be completely necessary for
survival [for a recent review see reference [19]]. Therefore,
little is known about the mechanisms by which B. cenoce-
pacia causes disease. Bacterial survival within host cells,
including epithelial cells [20] and macrophages [21-23],
may potentially provide a reservoir for bacterial persis-
tence [24]. Intracellular B. cenocepacia delay phagosomal
maturation [21,25] and assembly of the NADPH oxidase
[26,27], and alter the actin cytoskeleton [27-29]. Further-
more, intracellular B. cenocepacia can replicate within
macrophages [30]. The bacteria-containing phagosome
fuses with the lysosome and becomes acidified by 6 h
post-infection [21], suggesting that B. cenocepacia may be
able to replicate in an acidic environment.
To gain a full picture of bacterial adaption to the
macrophage cell host we investigated the gene expression
of intracellular bacteria upon internalization into macro-
phages. The study of gene expression by intracellular
bacteria is challenging since bacterial mRNA, which has
a short half-life, represents only a small fraction of total
bacterial RNA, which itself is only a small fraction of the
total RNA in infected host cells. Selective capture of tran-
scribed sequences (SCOTS) is a technique developed to
address these challenges and identify bacterial genes
expressed during infection. Previous studies in other bac-
teria have shown that SCOTS enriches microbial tran-
scripts without introducing a significant bias in gene
expression data [31]. This technique has been used to
identify genes expressed by several intracellular patho-
gens, including Mycobacterium tuberculosis [32], Salmo-
nella enterica serovar Typhi [33,34], Escherichia coli
O157:H7 [35], Legionella pneumophila [31], and Ehrli-
chia ruminantium [36].
In this study, we characterized gene expression by
intracellular B. cenocepacia during an early post-infection
stage in an attempt to identify gene products involved in
bacterial adaptive responses to the phagosomal environ-
ment. We demonstrate that B. cenocepacia alters gene
expression post-internalization, and that various upregu-
lated genes are involved in bacterial entry, intracellular
replication, and cytotoxicity towards the macrophage
host.
Results and discussion
Low abundance transcripts identified by competitive
enrichment
SCOTS was used to examine gene expression by intra-
cellular B. cenocepacia in murine macrophages at 4 h
post-infection. This interval was selected because at 4 h
post-infection most intracellular bacteria reside in pha-
gosomes that do not fuse with the lysosome [21,26,37];
infected macrophages also display observable alterations
of the actin cytoskeleton caused by the bacterial Type
VI secretion system (T6SS) [27,28], which is poorly
expressed in LB medium [28]. Therefore, 4 h post-infec-
tion provides a good window to document early changes
in bacterial gene expression in response to the intracel-
lular environment. As a control, we used bacteria grown
for 4 h in macrophage growth medium (DMEM-10%
FBS). To isolate and enrich bacterial transcripts, three
rounds of SCOTS were performed on both intracellular
and control bacterial cDNA samples. The resultant
cDNA pools were subjected to competitive enrichment
for transcripts specific to intra-macrophage bacteria.
This was accomplished by pre-blocking the chromosome
with both rDNA and control cDNA from non macro-
phage-exposed bacteria prior to capturing the cDNA
from intracellular bacteria. The procedure facilitates
capture of bacterial transcripts that are preferentially
expressed within the phagosome. After three rounds of
competitive enrichment, intracellular cDNA sequences
were cloned into pUC19 and introduced into E. coli
DH5a by transformation. DNA inserts from colonies
were individually amplified by PCR and screened by
Southern blot for differential hybridization to digoxi-
genin-labeled cDNA libraries. Many of the recombinant
plasmids obtained hybridized to labeled intracellular
cDNA but not to non macrophage-exposed cDNA
(Additional file 1, Figure S1). One hundred eighteen
unique sequences, encoding 124 proteins, were mapped
to the B. cenocepacia genome (Additional file 2, Table
S1); of these sequences, four were secondary sequences
within an already identified gene, two were within a dupli-
cated region on chromosome one, and one was a transpo-
sase gene with nine identical copies distributed throughout
the genome. Identified sequences were proportionally
represented in each of the three chromosomes and the
plasmid: 57 sequences mapped to chromosome one, 51 to
chromosome two, 14 to chromosome three, and 2 to the
plasmid. Identified genes were classified into functional
categories based on clusters of orthologous genes (COG)
designations (Figure 1). Almost half (46%) of identified
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genes, of which two-thirds had no COG classification. Of
the remaining genes, half were involved in metabolism,
one-third in cellular processes and signaling, and the
remainder in information storage and processing. Several
major COGs were not represented in the set, including
genes encoding functions of nucleotide metabolism and
transport, trafficking, secretion and transport, posttransla-
tional modification and chaperones, and defense mechan-
isms. In contrast, genes classified as encoding cell motility
functions were overrepresented relative to genome content.
Competitive enrichment and downstream screening do
not require specialized equipment, significant financial
outlay, or additional knowledge of the genome, and are
thus easily and rapidly applicable to any bacterium of
interest. Applying competitive enrichment to SCOTS-
derived cDNA identified trends in the intracellular beha-
vior of B. cenocepacia, as well as specific gene targets for
further study. However, analysis of global changes in
gene expression requires a high-throughput screening
system.
Global intracellular gene expression identified by
microarray analysis
To determine if the trends of intra-macrophage
expressed genes are representative of the entire cDNA
library, SCOTS-derived cDNA pools were applied to
B. cenocepacia-specific microarrays. Each cDNA pool
was hybridized against a reference sample of genomic
DNA, allowing comparison between samples. Of the 118
sequences initially identified by competitive enrichment,
80 percent showed higher expression by intracellular
bacteria than non-macrophage-exposed bacteria, validat-
ing the use of competitive enrichment as a preliminary
investigation technique. Twenty percent of sequences
identified by competitive enrichment showed significant
intracellular upregulation (> 2-fold, p < 0.05) of the
gene itself or putative transcriptionally associated gene
(s). In a global comparison of gene expression between
intracellular and non-macrophage-exposed bacteria, 767
genes or intergenic sequences demonstrated significant
changes in expression (-2 > log2 > 2, p < 0.05) (Addi-
tional file 3, Table S2), from which 330 and 437 showed
Figure 1 Functional classification by COG designation of intracellular selectively captured sequences. Profiles of the functional classes of
genes are shown as a percentage of all selectively captured sequences (scs). Also shown is the functional profile of the entire B. cenocepacia
genome.
Tolman and Valvano BMC Genomics 2012, 13:63
http://www.biomedcentral.com/1471-2164/13/63
Page 3 of 16increased and decreased expression, respectively. The
gene distribution among the three chromosomes and
the large plasmid of B. cenocepacia was relatively pro-
portionate to the size of the genetic element (Figure 2),
with the exception of the plasmid, where 20% of all
plasmid-encoded genes showed decreased expression by
intracellular bacteria.
To validate our results we first determined how many of
the genes obtained by the SCOTS method were pre-
viously identified by signature-tagged mutagenesis
(STM) as essential for in vivo survival. In the previous
s t u d yw em a p p e d8 4u n i q u et r a n s p o s o ni n s e r t i o n si n
genes that were associated with attenuation of bacterial
survival in a rat agar bead model of chronic lung infec-
tion [38]. Four of the STM genes were identified directly
by SCOTS using competitive enrichment, and another
three SCOTS-identified genes were found in genes
located within a putative transcriptional unit with an
STM insertion (Additional file 4, Table S3). The micro-
array analysis identified an additional 26 of the 84 STM
genes as being more highly expressed by intracellular
bacteria than non-macrophage-exposed bacteria. These
results were considered significant since bacterial survi-
v a li nar a ta g a rb e a dm o d e li n v o l v e sm o r et h a tj u s t
intra-macrophage survival.
A more direct validation of the SCOTS gene set was
performed by quantitative RT-PCR using a subset of
genes. Because bacterial RNA accounts for a very small
proportion of the total RNA isolated from infected cells,
an internal control was necessary to allow comparison
across samples. Sigma factor BCAM0918, or rpoD (also
designated sigA [39] or sigE [39,40]) was chosen due to
stable expression across growth phases and conditions
[41]. Despite reverse transcribing equal amounts of RNA
for each sample, intracellular samples averaged 60-fold
less rpoD transcripts than in non macrophage-exposed
samples, demonstrating the scarcity of bacterial RNA rela-
tive to eukaryotic content in the intracellular sample. To
account for this problem, expression of the gene of inter-
est was first related to the internal control, and this ratio
was compared between samples to give fold increase in
expression in intracellular bacteria. The test genes
included BCAM0314 (hypothetical protein), BCAM2141
(ABC transporter ATP-binding protein), BCAM0276
(putative universal stress protein), and BCAS0186 (puta-
tive acyl carrier protein phosphodiesterase), all of which
show high expression in intracellular bacteria. BCAM1928
(putative transcription elongation factor) was chosen as an
example of a gene with decreased expression in intracellu-
lar bacteria. qRT-PCR confirmed higher expression of
BCAM0314, BCAM2141, BCAM0276, and BCAS0186
(Additional file 5, Figure S2); expression of negative con-
trol BCAM1928, though detectable in both samples, was
far lower in intracellular bacteria than in non-
macrophage-exposed bacteria, with a fold change ratio of
3.2 × 10
-3 ±2 . 8×1 0
-3.B a s e do nt h ec o m p a r i s o no ft h e
SCOTS results with STM data and the results of qRT-
PCR, we concluded that the set of genes identified by
microarray provides a good representation of the B. ceno-
cepacia transcriptome in the phagosome at 4 h post
infection.
Differentially regulated genes identified by microarray
were classified into functional categories based on COG
designations (Figure 3). Globally, our results indicate
that internalization of B. cenocepacia by macrophages
causes large changes in the expression of genes asso-
ciated with signal transduction mechanisms and tran-
scription, showing that B. cenocepacia senses the
phagosomal environment and activates mechanisms
necessary for survival in a new niche. Adaptive gene
expression is a continual process, as transcription-asso-
ciated genes remain among the most-affected at 4 h
post-infection (Figure 4). Metabolic adaptation accounts
for one-third of differentially regulated genes in intracel-
lular bacteria. In particular, genes involved in carbohy-
drate transport and metabolism were prominently
upregulated in intracellular bacteria, accounting for 6%
of all differentially upregulated genes (Figure 3). In
Leishmania, a protozoan parasite that delays phagoso-
mal maturation and replicates in an acidified phagolyso-
some, the phagolysosome contains various carbon
sources and essential nutrients, but lacks carbohydrates
[42], which could explain the upregulation of carbohy-
drate metabolism pathways. We speculate that in similar
fashion, the upregulation by intracellular B. cenocepacia
of genes involved in carbohydrate metabolism is a con-
sequence of the low carbohydrate content in the phago-
somal lumen. This also agrees with the observation that
some of the most highly expressed genes in intracellular
B. cenocepacia are those involved in amino acid trans-
port (Figure 4). Similar findings were reported for other
pathogens, which upregulate amino acid transport sys-
tems during intracellular growth [31,34,43], suggesting
amino acid acquisition from the host may be a general
strategy of intracellular bacteria to obtain carbon and
nitrogen. However, with nearly 40% of the genes most
affected by internalization falling into the poorly charac-
terized category (Figure 4), it is likely that B. cenocepa-
cia also employs novel survival strategies.
Intracellular bacteria showed decreased expression of
genes involved in siderophore-mediated iron acquisition,
including those encoding the ornibactin receptor, the
transcriptional activator of the pyochelin receptor, and a
putative pyochelin biosynthesis protein (Additional file
3, Table S2). Ornibactin contributes to colonization,
bacterial persistence, and lung pathology in murine
models of acute and chronic lung infection [44]. Orni-
bactin, however, may not be required for iron uptake by
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Page 4 of 16Figure 2 Distribution of genes differentially expressed by intracellular B. cenocepacia among the four genomic replicons. The outer pair
of concentric circles represents both coding strands of the B. cenocepacia genome. The second pair of concentric circles represents genes with
increased (outer) and decreased (inner) expression by intracellular B. cenocepacia. Percentage of G+C is also shown, with above average in
yellow and below average in purple. Chromosome 3 is 3x scale; the plasmid is 17.5x scale.
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Page 5 of 16intracellular bacteria, as the phagosome appears to be
rich in iron content [45-47].
The large number of genes in the Burkholderia genus,
and specifically in B. cenocepacia [18], endows these bac-
teria with redundant nutrient uptake systems to function
under different conditions and perhaps even exploit multi-
ple forms of similar metabolites. Thus, the changes
observed in the expression of metabolic genes may reflect
the ability of B. cenocepacia to utilize resources present in
the phagolysosome. Since intracellular bacteria only delay
phagolysosomal fusion and reside in a phagosome that
remains in contact with the endocytic pathway [21], it
w o u l db er e a s o n a b l et op r o p o s et h a tt h ep h a g o s o m a l
maturation delay allows B. cenocepacia to become adapted
to survive in low pH environment. The results of our
SCOTS analysis support the notion that intracellular B.
cenocepacia may adapt to survive in a low pH environ-
ment. Indeed, BCAS0167, one of the two genes encoding
the squalene-hopene cyclase for the synthesis of hopa-
noids, was strongly upregulated by intracellular bacteria.
Production of cholesterol-like hopanoids in certain
bacteria, including B. cenocepacia [48] contributes to
membrane stability under acidic environments [48,49].
Furthermore, the upregulation of a putative sodium:solute
symporter and a Na
+/H
+ antiporter suggests that proton-
driven high-affinity uptake by metabolite:proton sympor-
ters is important for intracellular B. cenocepacia to bring
nutrients into the cell under acidic conditions [50].
SCOTS-identified genes are involved in bacterial entry,
intracellular replication, and macrophage cytotoxicity
Because survival within macrophages may contribute to
the pathogenesis of B. cenocepacia,t h er o l eo fs e v e r a l
SCOTS-identified genes in intracellular survival was exam-
ined. Ten genes, chosen based on their high intracellular
expression by microarray data or identification by compe-
titive enrichment, were selected for deletion in the genta-
micin-sensitive B. cenocepacia MH1K. This strain is
isogenic with K56-2 but allows intracellular bacterial survi-
val to be assessed via the gentamicin protection assay [30].
The ten deleted genes were: BCAL0124 (subunit of the fla-
gellar regulon master regulator), BCAS0186 (putative acyl
Figure 3 Functional classification by COG designation of genes differentially expressed by intracellular B. cenocepacia. Profiles of
functional classes are shown as a percentage of all genes with significantly increased (green bar) or decreased (red bar) expression (-2 > log2 >
2, p < 0.05).
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Page 6 of 16carrier protein phosphodiesterase), BCAM0434-5, (cation
efflux system), BCAM2837 (response regulator component
of a two-component regulatory system), BCAL1726 (puta-
tive oxidoreductase), BCAM0276 (putative universal stress
protein), BCAM0411 (MgtC family protein), BCAL0340
(putative lipoprotein), BCAM1679, (putative lysylphospha-
tidylglycerol synthetase), and BCAM2446 (putative outer
membrane porin).
The ability of mutant strains to enter and replicate
within macrophages was assessed relative to the parental
strain. Only BCAL0124 (p <0 . 0 1 )a n dB C A M 0 4 1 1( p <
0.05) showed statistically significant defects in macrophage
entry, while deletion of BCAL1726 resulted in a significant
increase in macrophage entry (p <0 . 0 0 1 )( F i g u r e5 A ) .
None of the deletions negatively affected intracellular sur-
vival, but deletions in BCAL0340 and BCAM0411
increased the ability of the bacteria to replicate intracellu-
larly (Figure 5B). With the exception of ΔBCAL1726,
statistically significant differences in entry and intracellular
survival could be complemented by introducing the
deleted gene encoded in a plasmid under the control of a
constitutive promoter (Figure 5C-D). The lack of comple-
mentation of ΔBCAL1726 suggests the possibility of a sec-
ondary mutation. Alternatively, because BCAL1726 is
predicted to be the first in a four-gene operon, the deletion
may affect downstream genes, thereby preventing possible
complementation by BCAL1726 alone.
The results of the gentamicin protection assay may be
misleading if the survival of the host cell is not consid-
ered, as bacterial cytotoxicity causing membrane damage
to the host cell would allow entry of the antibiotic and
result in the killing of intracellular bacteria. The viability
of Burkholderia-infected macrophages was assayed by
flow cytometry using the impermeant fluorescent dye 7-
AAD, which binds DNA only in macrophages with per-
meabilized membranes. Macrophages were infected with
Figure 4 Relative expression of genes with the greatest fold-change in intracellular B. cenocepacia. Heat map shows the 100 genes with
the greatest ± fold-change (p < 0.05) in expression in intracellular bacteria relative to non-macrophage-exposed bacteria. Color scale from -60 to
+60-fold change is indicated, with expression increased > 60-fold in blue, and decreased > 60-fold in purple. “BCA” has been omitted from gene
names.
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parameters: entry, cytotoxicity, and spread. Parental B.
cenocepacia was found in 3% of all macrophages, and
was cytotoxic to macrophages at a 1:1 ratio, killing
approximately 3% of all cells (Figure 6A). The only
mutant displaying statistically significant differences
from the parental isolate was ΔBCAM2837; despite
infecting nine-fold better than the parental isolate,
ΔBCAM2837 was also cytotoxic at a 1:1 ratio, killing
27% of all macrophages. Some mutants, including
ΔBCAM0276 and ΔBCAM2446, appeared to prevent per-
meabilization of the macrophage membrane, decreasing
Figure 5 Comparative macrophage entry and intracellular replication of parental and mutant B. cenocepacia. Entry (A) was calculated
relative to initial inoculum, and replication (B) was calculated relative to entry; both were normalized relative to the parental control, set at 100%
entry and 100% replication. Significance was determined using one-way ANOVA and Dunnett’s Multiple Comparison Test. Mutants with a
statistically significant difference from the parental strain (*p < 0.05, **p < 0.01, ***p < 0.001) could be complemented for both entry (C) and
replication (D). Plasmid pDA12 is a vector control; pJTx is a complementation plasmid. Error bars indicate the standard error of the mean of at
least three independent experiments. Vector control and complemented strains were compared using Student’s t test; statistically significant
differences are indicated above the lines.
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phages (Figure 6A). Of the ten mutants, only four were
cytotoxic, defined as permeabilization of the host cellular
membrane greater than seen in uninfected cells. The nor-
malization of intracellular replication quantified by the
gentamicin protection assay against the rate of cytotoxicity
quantified by flow cytometry provided a better overall
assessment of the potential role of the genes examined in
our study. Normalization revealed significant intracellular
replication by ΔBCAL0124 (Figure 6C). Normalization
also showed that ΔBCAL0340 replicates at a rate similar
to the parental isolate, but is protected from gentamicin
because it is less cytotoxic. In contrast, ΔBCAL1726 is
more cytotoxic than the parental strain (Figure 6C), and,
despite initially infecting at a higher level, has likely been
killed by gentamicin entering dying host cells. Mutants
that displayed a cytotoxic ratio (Figure 6B) less than zero
were not normalized, as in the absence of membrane per-
meability defects, intracellular bacteria would not be inhib-
ited by gentamicin.
Flow cytometry also permitted investigation of possible
intercellular spread of B. cenocepacia in an unchecked
infection. After killing extracellular bacteria, infected
macrophages were maintained in antibiotic-free media.
Under these conditions any bacteria escaping the macro-
phage would be able to infect neighboring macrophages.
The results of this experiment showed that the number of
macrophages infected with the parental strain increased
six-fold (Figure 7), suggesting that B. cenocepacia was able
to escape the macrophage and be engulfed by neighboring
macrophages. With the exception of ΔBCAM2837, the
mutant strains spread at least as well as the parental iso-
late; both ΔBCAL1726 and ΔBCAM1679 showed signifi-
cantly increased spread relative to the parental strain,
more than doubling the number of infected macrophages.
The ratio of dead:infected cells generally remained
approximately 1:1 in an unchecked infection, suggesting
that viable B. cenocepacia escaped from dead macrophages
rather than by an active process of exocytosis. The two
exceptions to this were ΔBCAL0124, which killed 2.5 cells
for every cell infected at the time of analysis, and
ΔBCAM2837, which killed only 30% of infected cells.
The phenotypes seen in individual gene deletions under-
score several of the trends seen in the global characteriza-
tion of intracellular gene expression. The importance of
cellular motility suggested by the upregulation of such
genes by intracellular bacteria is supported by the pheno-
types seen in ΔBCAL0124 and ΔBCAM2837. BCAL0124
encodes FlhD, a subunit of the flagellar regulon master
regulator necessary for expression of the flagellar struc-
tural components [51]. BCAM2837, a pseudogene in
sequenced type strain J2315, is annotated as the response
regulator component of a two-component regulatory sys-
tem. Bioinformatic analysis shows that the protein consists
Figure 6 Comparative bacterial infection, host cytotoxicity, and
normalized replication of parental and mutant B. cenocepacia.
Bacterial infection and cytotoxicity (A) are shown as a percentage of
total cells. Cytotoxicity was normalized against cell death in
uninfected cells. 50 000 cells were counted in each of three
independent experiments. Standard error bars are indicated.
Significance was determined using one-way ANOVA and Dunnett’s
Multiple Comparison Test. Mutants demonstrating significant
difference from the wild-type are indicated (*p < 0.05, **p < 0.01,
***p < 0.001). The ratio of dead cells: infected cells (B) was used to
correct intracellular replication determined by the gentamicin
protection assay to give the total expected ratio of intracellular
bacteria in the absence of cell death (C). Mutants with a ratio in (B)
less than zero are unchanged in (C).
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taxis protein CheC, and the second homologous to the
response regulator CheY. Che proteins are typically
involved in chemotaxis [52], where CheC is a phosphatase
that dephosphorylates CheY [53]. The genetic organization
o fB C A M 2 8 3 7s u g g e s t st h a tt h i sg e n ei sc o t r a n s c r i b e d
with genes encoding putative diguanylate cyclase and histi-
dine kinase proteins. B. cenocepacia carries three other
cheY homologues [54,55], which are expressed in intracel-
lular bacteria while there is one cheC-like gene,
BCAL0136, which is not well expressed intracellularly.
Therefore, we speculate that the product of BCAM2837 is
part of a complex signal transduction cascade required for
bacteria to move away from the phagocytic cell, which
may also affect bacterial escape from dying macrophages.
The mutant strain lacking BCAL0124 is non-motile, while
ΔBCAM2837 is capable of swimming, but is defective in
swarming (Additional file 6, Figure S3). The two mutants
are significantly different in their uptake by macrophages,
suggesting that the presence of flagella may be important
to stimulate phagocytosis. Loss of the bacterial flagella
through deletion of fliCD also results in a severe defect in
bacterial internalization by macrophages (Additional file 7,
Figure S4). The requirement of flagellin for efficient
macrophage engulfment was previously noted in B. pseu-
domallei [56] and P. aeruginosa [57]. In contrast, bacteria
with a motility defect may lose the ability to actively evade
phagocytosis, resulting in increased uptake as seen in
ΔBCAM2837. The two mutants also vary in their rates of
intracellular replication, host cytotoxicity, and cell spread.
B. cenocepacia lacking flagellin is unable to activate NFB
or elicit secretion of IL-8 through TLR signaling [58].
Therefore, it is possible that ΔBCAL0124 bacteria avoid
activation of classical proinflammatory signaling cascades,
allowing undetected intracellular replication until over-
whelming the macrophage and escaping to re-infect neigh-
boring cells. In contrast, the decreased ability to spread
and lower cytotoxicity suggest that ΔBCAM2837 may kill
and escape macrophages more slowly, potentially resulting
from a defect in swarming motility. The importance of the
flagella to the interaction between B. cenocepacia and
m a c r o p h a g e si sn o tu n i q u e ,a su p r e g u l a t i o no ff l a g e l l a r
genes is also seen in intracellular L. pneumophila [31].
Genes involved in membrane biogenesis and modifica-
tion, as well as trafficking across the membrane were
highly regulated by intracellular bacteria (Figure 3). Gen-
eral systems involved in the biogenesis of membrane pro-
teins such as the first gene of the Tat system, several genes
in the Sec system, and the signal recognition particle RNA
showed decreased expression by intracellular bacteria. In
contrast, increased expression of T6SS genes was seen in
intracellular bacteria. Deletion of BCAL0340, encoding a
putative lipoprotein central to the T6SS cluster, promotes
replication of intracellular bacteria (Figure 5) but does not
inactivate the T6SS, as evidenced by the appearance of
actin-rich protrusions in infected macrophages, a typical
phenotype of a functionally active T6SS. In a previous
study, three transposon mutants within the T6SS cluster
showed attenuated survival in an in vivo rat model of
chronic lung infection [38], corroborating the importance
of a functional T6SS to infection. Genes involved in modi-
fication of the membrane were also highly expressed by
intracellular bacteria. BCAM1679 encodes a putative lysyl-
phosphatidylglycerol (Lys-PG) synthetase which adds
Figure 7 Spread of B. cenocepacia and host cytotoxicity in an
unchecked infection of murine macrophages. Capacity to spread
(A) is calculated as the fold-increase in infected macrophages when
maintained in antibiotic-free media rather than 10 μg/ml
gentamicin in the same experiment. Host cytotoxicity (B) is
calculated as the ratio of total dead cells to infected cells. 50 000
cells were counted in each of three independent experiments.
Standard error bars are indicated. Significance was determined
using one-way ANOVA and Dunnett’s Multiple Comparison Test.
Mutants demonstrating significant difference from the wild-type are
indicated (*p < 0.05, **p < 0.01, ***p < 0.001).
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Page 10 of 16lysine to PG, thereby lowering the net negative charge of
the cellular envelope, already lowered in B. cenocepacia by
the constitutive presence of 4-amino-4-deoxy-L-arabinose
linked to lipid A [59]. Lys-PG may also decrease perme-
ability to cations and protons by raising the surface poten-
tial of the membrane, increase membrane fluidity, inhibit
genomic DNA replication, and decrease activity of the
host defense factor phospholipase A2 (PLA2) (reviewed in
[60]). Deletion of BCAM1679 caused extensive spread in
an unchecked infection (Figure 7). Since secreted PLA2
can hydrolyze the membrane of cells undergoing early
stages of apoptosis [61], it is possible that macrophages
infected with ΔBCAM1679 undergo apoptosis and intra-
cellular bacteria could escape from apoptotic cells to re-
infect neighboring cells.
Previous studies have demonstrated that B. cenocepa-
cia is cytotoxic to epithelial cells [62-64] and causes
necrosis of dendritic cells [65]. Our results indicate that
t h es a m ei st r u ef o rm a c r o p h a g e s .T h em e c h a n i s mo f
macrophage cell death induction by B. cenocepacia is
under investigation in our laboratory [66,67]. Pilin-
mediated apoptosis induced by B. cenocepacia in
infected epithelial cells has been documented and
shown to depend on the bacterial load [62]. However,
production of IL-1b by infected macrophages indicates
inflammasome-mediated caspase-1 activation, which can
lead to pyroptosis [67]. Pyroptosis also induces lysosome
exocytosis, whereby any bacteria residing within a lyso-
some are freely delivered to the extracellular milieu as
the lysosome fuses with the macrophage plasma mem-
brane, which would explain the mechanism of bacterial
release and reinfection of neighboring macrophages.
Conclusions
Our results indicate that the intracellular survival of
B. cenocepacia i nm a c r o p h a g e si sa s s o c i a t e dw i t hp r o -
found changes in metabolic activity and motility rather
than the expression of more traditional “virulence-speci-
fic” genes. These observations are consistent with the
ability of B. cenocepacia to adapt and survive in a broad
range of niches. Our data also show that the delay of
phagosomal maturation provides sufficient time for
intracellular bacteria to undergo changes in gene expres-
sion that likely provide a growth advantage in the pha-
golysosomal compartment. Therefore, B. cenocepacia is
an opportunistic pathogen with the capacity to adapt to
survive intracellularly until bacteria can escape back to
the extracellular milieu.
Methods
Bacterial strains, plasmids, media, and growth conditions
Bacterial strains and plasmids used in this study are listed
i nT a b l e1 .B a c t e r i ag r e wa t3 7 ° Ci nL u r i a - B e r t a n i( L B ;
Difco) broth with agitation or on LB plates with 1.6%
Bacto agar. Escherichia coli cultures were supplemented as
required with 20 μg/ml tetracycline, 50 μg/ml trimetho-
prim, and 40 μg/ml kanamycin; B. cenocepacia cultures
were supplemented as required with 100 μg/ml tetracy-
cline and 100 μg/ml trimethoprim. Plasmids were conju-
gated into B. cenocepacia by triparental mating at 37°C
using E. coli DH5a carrying the helper plasmid pRK2013
[68]. E. coli donor and helper strains were selected against
with gentamicin (50 μg/ml) or ampicillin (100 μg/ml) and
polymyxin B (25 μg/ml).
Molecular techniques
DNA manipulations were performed as in [69]. DNA was
amplified by PCR in a PTC-221 DNA engine (MJ
Research) with Taq DNA polymerase or HotStar DNA
polymerase (Qiagen). Amplification of B. cenocepacia
DNA was aided by including the Qiagen Q solution. DNA
sequencing was performed at the York University Core
Molecular Biology and DNA Sequencing Facility in Tor-
onto, Ontario, Canada. Restriction enzymes, T4 DNA
ligase (Roche Diagnostics) and Antarctic alkaline phospha-
tase (New England Biolabs) were used as recommended
by manufacturers. Transformation of E. coli SY327 and
DH5a was done by the calcium chloride protocol [70].
Cell culture and infection
Macrophage cell lines (Table 1) were maintained in Dul-
becco’s modified Eagle medium (DMEM; Wisent) supple-
mented with 10% fetal bovine serum (FBS; Wisent) at 37°C
in a 95% humidified atmosphere with 5% CO2.F o rm a c r o -
phage infection, cells were seeded in a 12-well plate at 1.25
×1 0
5 cells per well or a 6-well plate at 2.5 × 10
5 cells per
well and grown 15 h. Bacterial cultures grown at 37°C for
16 h were washed twice and resuspended in DMEM-10%
FBS. Macrophage monolayers were washed with phos-
phate-buffered saline (PBS; Wisent). Bacteria were added
at a multiplicity of infection (MOI) of 50:1 or 10:1 in 1-2
ml DMEM-10% FBS. Plates were centrifuged 1 min at
300 × g and incubated at 37°C, 95% humidity and 5% CO2.
RNA extraction, cDNA synthesis, and amplification
RNA was extracted from two 6-well plates containing
equal numbers of B. cenocepacia, differing only in the pre-
sence (intracellular (I) RNA) or absence (non-macro-
phage-exposed RNA) of macrophages. At 4 h post-
infection, macrophage monolayers were washed three
times with PBS and lysed in 1 ml cold deionized H2O.
Non macrophage-exposed bacteria were resuspended and
collected. For each condition, cells from 6 wells were
resuspended in 1 mg/ml lysozyme (Roche). Total RNA
was extracted using TRIzol (Invitrogen) and treated with
RNase-free DNase (Roche) according to the manufac-
turer’s instructions. RNA purity, integrity, and concentra-
tion were determined by PCR, agarose gel electrophoresis,
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Page 11 of 16and A260/A280 spectrophotometer readings, respectively. A
5 μg RNA sample from each condition ("intracellular” and
“non macrophage-exposed”) was converted to first-strand
cDNA by random priming with Transcriptor reverse tran-
scriptase (Roche) according to the manufacturer’s
specifications. Primers had a defined 5’ terminal sequence
and a 3’ random nonamer; different terminal sequences
were used for intracellular (I-3025) and non macrophage-
exposed RNA (N-3017) (Additional file 8, Table S4).
cDNAs were double-stranded using Klenow fragment
Table 1 Strains, plasmids, and cell lines used in this study
Strain, cell line, or plasmid Relevant characteristics
a Source or reference
Escherichia coli
DH5a F
-, ɸ 80 lacZ DM15 Δ(lacZYA-argF)U169 endA1 recA1 hsdR17 (rK
- mK
+) supE44 thi-1 ΔgyrA96 relA1 Laboratory stock
SY327 araD Δ(lac pro) argE(Am) recA56 rifr nalA, l pir [75]
Burkholderia cenocepacia
J2315 Epidemic strain ET12 clone, CF clinical isolate P.A. Sokol
K56-2 Epidemic strain ET12 clone, CF clinical isolate BCRRC
b
MH1K K56-2 ΔBCAL1674-6 [30]
JST19 MH1K ΔBCAL0124 This study
JST71 MH1K ΔBCAS0186 This study
JST75 MH1K ΔBCAM2837 This study
JST128 MH1K ΔBCAL1726 This study
JST130 MH1K ΔBCAM0276 This study
JST132 MH1K ΔBCAM0411 This study
JST134 MH1K ΔBCAM2446 This study
JST136 MH1K ΔBCAM0434-5 This study
JST190 MH1K ΔBCAL0340 This study
JST194 MH1K ΔBCAM1679 This study
Macrophage cell lines
ANA-1 C57BL/6 murine bone marrow-derived macrophages [76]
RAW 264.7 BALB/c murine macrophage cell line ATCC
c
Plasmid
pDA12 oripBBR1, Tet
R, mob
+,P dhfr [28]
pDA42 pDA12, eGFP [28]
pDAI-SceI-SacBN oripBBR1, Tet
R, mob
+,P dhfr, sacB, encodes I-SceI endonuclease [30]
pDelbcsM pGPI-SceI with regions flanking BCAL0340 [77]
pGPI-SceI oriR6K,T p
R, mob
+, carries I-SceI cut site [74]
pJT25 pUC19 with K56-2 rDNA (23S, 16S, 5S), Ap
R This study
pJT31 pGPI-SceI with regions flanking BCAL0124 This study
pJT41 pGPI-SceI with regions flanking BCAS0186 This study
pJT42 pGPI-SceI with regions flanking BCAM2837 This study
pJT45 pGPI-SceI with regions flanking BCAL1726 This study
pJT46 pGPI-SceI with regions flanking BCAM0276 This study
pJT47 pGPI-SceI with regions flanking BCAM0411 This study
pJT48 pGPI-SceI with regions flanking BCAM2446 This study
pJT49 pGPI-SceI with regions flanking BCAM0434-5 This study
pJT52 pDA12, BCAL1726 This study
pJT54 pDA12, BCAM0411 This study
pJT57 pDA12, BCAL0124 This study
pJT71 pDA12, BCAL0340 This study
pJT72 pGPI-SceI with regions flanking BCAM1679 This study
pRK201 RK2 derivative, Km
R, mob
+, tra
+, oricolE1 [68]
pUC19 oripMB1,A p
R, mob
+,P lac [78]
a Tp, trimethoprim; Tet, tetracycline; Ap, ampicillin; Km, kanamycin
b B. cepacia complex Research and Referral Repository for Canadian CF Clinics
c American Type Culture Collection
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Page 12 of 16(Roche) as described in [71]; cDNA libraries were ampli-
fied for 25 cycles using defined primers I-3032 (intracellu-
lar) or N-3033 (non macrophage-exposed).
Selective capture of transcribed sequences
The SCOTS protocol was carried out as in [72]. Briefly,
0.3 μg of denatured, sonicated, biotinylated B. cenocepa-
cia K56-2 chromosome were mixed with 5 μg denatured
ribosomal DNA fragments (sonicated pJT25; Table 1)
and hybridized 30 min at 68°C to pre-block rRNA-
encoding DNA regions. 3 μg of cDNA were denatured
and re-annealed 30 min at 68°C to remove abundant
transcripts. cDNA and chromosomal DNA were com-
bined and hybridized 24 h at 68°C. Chromosome-cDNA
hybrids were removed from solution with streptavidin-
coated magnetic beads (Invitrogen). Captured cDNA
was eluted, precipitated, and amplified using library-spe-
cific defined primers (Additional file 8, Table S4). For
each condition, 10 parallel first-round reactions were
done to maximize the cDNA sample diversity; the resul-
tant cDNA was pooled for each condition and two sub-
sequent rounds of SCOTS carried out. The final cDNA
libraries were used both for competitive enrichment
hybridization and as probes for B. cenocepacia
microarrays.
Competitive enrichment
To preferentially enrich for intramacrophage-expressed
transcripts, 0.3 μgo fB. cenocepacia K56-2 chromosome
was pre-blocked with both 5-μgr D N Aa n d1 0μgo fd e n a -
tured triple-SCOTS enriched non macrophage-exposed
cDNA (above). 3 μg of triple-SCOTS enriched intracellular
cDNA (above) was denatured and re-annealed 30 min at
68°C to remove abundant transcripts. cDNA and blocked
chromosomal DNA were combined and hybridized 18 h
at 68°C. Chromosome-cDNA hybrids were removed from
solution with streptavidin-coated magnetic beads. Cap-
tured cDNA was eluted, precipitated, and amplified using
intracellular library-specific defined primer I-3032. Follow-
ing three rounds of enrichment, cDNA were digested with
restriction enzyme XbaI, cloned into XbaI-digested,
dephosphorylated pUC19, and transformed into E. coli
DH5a. Individual cDNA inserts were screened by South-
ern blot for hybridization to DIG-labeled cDNA libraries.
cDNA that hybridized to intracellular cDNA, but not to
non macrophage-exposed cDNA, were sequenced and
identified by BLAST analysis.
Microarray experimental design and analysis
SCOTS cDNA or B. cenocepacia J2315 genomic DNA was
labeled with CyScribe™ Array CGH Labeling Kit (GE
Healthcare) according to the manufacturer’sp r o t o c o l s .
SCOTS cDNA was labeled with Cy5 and genomic DNA
with Cy3; cDNA samples were mixed, hybridized to
custom B. cenocepacia microarrays (Agilent) according to
the Agilent 60-mer oligonucleotide microarray processing
protocol, and scanned. Labeling of cDNA, hybridization,
and scanning of arrays were performed by the Mahenthir-
alingam Laboratory, Cardiff University, Wales. Microarray
data analysis was done using GeneSpring GX 7.3.1 (Agi-
lent). Raw data was preprocessed via the enhanced Agilent
FE import prior to per-spot and per-chip normalizations
for each array. Feature intensity varied across the six
arrays. Statistical analysis between intracellular and non-
macrophage-exposed conditions was performed using a
paired Student’s t-test; genes were considered differentially
expressed at an intracellular:non macrophage-exposed
ratio of ± 2-fold with a p <0 . 0 5 .
The microarray dataset has been deposited in the
ArrayExpress database http://www.ebi.ac.uk/arrayex-
press/ under accession number E-MEXP-3408.
Quantitative reverse transcriptase PCR (qRT-PCR)
To validate microarray data, five genes with altered
expression (4 upregulated: BCAM0314, BCAM2141,
BCAM0276, and BCAS0186; and 1 downregulated:
BCAM1928) were examined individually using qPCR.
Sigma factor gene rpoD (BCAM0918) was used as a refer-
ence gene. Oligonucleotide primers for each gene (Addi-
tional file 8, Table S4) were designed with Primer3 [73].
Total RNA was isolated as described above. cDNA was
synthesized using random hexamers (Invitrogen) and
Transcriptor reverse transcriptase. Quantitation and melt-
ing curve analyses for qPCR were performed using the
Rotor Gene 6000 (Corbett Life Science) with FastStart
SYBR Green (Roche) according to the manufacturer’s
instructions. Expression of the target gene was normalized
to the reference gene for each condition, allowing inter-
condition comparison. Data shown are representative of at
least two independent experiments.
Mutagenesis of B. cenocepacia K56-2
The I-SceI homing endonuclease system was used to con-
struct unmarked deletions of genes or gene clusters in
B. cenocepacia K56-2 [74]. Briefly, regions flanking the
gene or genes to be deleted were amplified with gene-spe-
cific primers containing restriction sites (Additional file 8,
Table S4). Upstream amplicons were digested with restric-
tion enzymes XbaI-ClaI; downstream amplicons were
digested with ClaI-EcoRI. Both upstream and downstream
amplicons were cloned into XbaI-EcoRI digested, de-phos-
phorylated pGPI-SceI, giving rise to mutagenesis plasmids
(Table 1). Mutagenesis plasmids were introduced into
either B. cenocepacia K56-2 or MH1K by triparental mat-
ing. Plasmid pDAI-SceI-SacBN, encoding the homing
endonuclease, was conjugated into single crossover
mutants, causing a double-strand break resolved by either
a second crossover, yielding mutant genotype, or by
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Page 13 of 16reversion to wild-type. Exconjugants were screened by
PCR, and confirmed mutants were plated on LB with 5%
sucrose to cure pDAI-SceI-SacBN. PCR confirmed that
the deletion had occurred, yielding gentamicin-sensitive
mutants (Table 1).
Complementation experiments
To complement single gene deletions, wild-type genes
were PCR amplified from B. cenocepacia K56-2 with
gene-specific primers (Additional file 8, Table S4) and
the following thermal cycling conditions: 95°C for 5 min-
utes, 30 cycles of 95°C for 45 s, 60°C for 45 s, and 72°C
for 90 s, and a final extension at 72°C for 10 min. The
resulting amplicon was digested with restriction enzymes
XbaIa n dNdeI, and ligated into XbaI/NdeI-digested,
dephosphorylated pDA12, giving rise to a complementa-
tion plasmid (Table 1), which could be introduced to the
mutant strain through conjugation. pDA12 was used as a
vector control in all experiments. Statistically significant
differences between vector control and complemented
strains were determined using Student’s t test.
Gentamicin protection assays
Thirty min post-infection, B. cenocepacia-infected cells
were washed three times with PBS and DMEM-50 μg/
ml gentamicin was added to kill extracellular bacteria.
After 30 min, the media was replaced with DMEM-10
μg/ml gentamicin. Infected monolayers were washed
with PBS, and lysed with 0.1% Triton X-100 (Sigma) in
PBS at 1 and 24 h post-infection. Surviving bacteria
were enumerated by bacterial plate count (CFU). Bacter-
ial entry was calculated as a percentage of initial inocu-
lum. Intracellular replication was calculated as a
percentage of bacterial entry for each strain. To com-
pare between experiments, percentage recovery was nor-
malized against the parental control, set as 100% entry
and replication. Statistical analysis was performed using
one-way ANOVA and Dunnett’s Multiple Comparison
Test.
Flow cytometry
B. cenocepacia expressing eGFP from the plasmid pDA42
[28] were infected as above in 12-well plates at a multipli-
city of 50:1. At 2 h post-infection cells were washed three
times with PBS and DMEM-50 μg/ml gentamicin was
added to kill extracellular bacteria. After 30 min, the
medium was replaced with DMEM with and without
gentamicin (10 μg/ml). Infected monolayers were washed
with PBS, and removed with cold 0.04% EDTA in PBS at
24 h post-infection. Cells maintained in media with gen-
tamicin represented initial infection, while cells main-
tained in antibiotic-free media represented uncontrolled
infection. Macrophages were collected by centrifugation
for 5 min at 400 × g and 4°C. Cells were resuspended in
cold PBS with 2.5 μg/ml 7-aminoactinomycin D (7AAD;
Invitrogen) and maintained on ice. Samples were enum-
erated using a FACSCalibur with CellQuest Pro acquisi-
tion software (Becton Dickinson). Data analysis was done
with FlowJo (Tree Star, Inc.). All results were normalized
against uninfected controls. Statistical analysis was per-
formed using one-way ANOVA and Dunnett’s Multiple
Comparison Test.
Additional material
Additional file 1: Figure S1-Bacterial transcripts specific to
intracellular B. cenocepacia can be identified by differential
hybridization.
Additional file 2: Table S1-Intracellular-specific selectively captured
sequences.
Additional file 3: Table S2-Genes with significantly higher or lower
expression by intracellular B. cenocepacia. Genes included show
greater than 2-fold change in expression (p < 0.05) in intracellular
bacteria relative to non-macrophage-exposed bacteria. The first sheet
contains genes with increased intracellular expression, the second genes
with decreased intracellular expression.
Additional file 4: Table S3-In vivo essential genes with increased
expression in intracellular bacteria.
Additional file 5: Figure S2-Fold change gene expression of
selected SCOTS-identified genes measured by qRT-PCR.
Additional file 6: Figure S3-ΔBCAL0124 and ΔBCAM2837 are
defective in motility.
Additional file 7: Figure S4-Flagellin is necessary for efficient
bacterial entry into macrophages.
Additional file 8: Table S4-Oligonucleotide primers used in this
study.
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